{"entity":{"type":"insider","cik":"0001994805","url":"/insider/0001994805","json_url":"/insider/0001994805.json","name":"Edwards Larry Todd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2024-05-20","last":"2026-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Edwards Larry Todd","source":"filing","n_filings":9,"first_seen":"2024-05-20","last_seen":"2026-03-03"}],"transactions":[{"id":6055865,"accession":"0001628280-26-014328","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-014328","line_url":"/filing/0001628280-26-014328","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3687.0,"shares_display":"3,687","price_per_share":25.182060943856794,"price_display":"25.18","price_state":"stated","total_value":92846.2587,"total_display":"92,846.26","total_whole":"92,846","shares_owned_after":175281.0,"shares_owned_after_display":"175,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider","n_lines":2},{"id":6137952,"accession":"0001628280-26-005566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-005566","line_url":"/filing/0001628280-26-005566#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2052.0,"shares_display":"2,052","price_per_share":25.4984,"price_display":"25.50","price_state":"stated","total_value":52322.7168,"total_display":"52,322.72","total_whole":"52,323","shares_owned_after":148865.0,"shares_owned_after_display":"148,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4484547,"accession":"0001994805-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001994805-25-000008","line_url":"/filing/0001994805-25-000008#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29131.0,"shares_display":"29,131","price_per_share":25.1597,"price_display":"25.16","price_state":"stated","total_value":732927.2207,"total_display":"732,927.22","total_whole":"732,927","shares_owned_after":150193.0,"shares_owned_after_display":"150,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-06","filed_date":"2025-11-10","scope":"insider"},{"id":4780766,"accession":"0001994805-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001994805-25-000005","line_url":"/filing/0001994805-25-000005","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4504.0,"shares_display":"4,504","price_per_share":20.04069920071048,"price_display":"20.04","price_state":"stated","total_value":90263.3092,"total_display":"90,263.31","total_whole":"90,263","shares_owned_after":178897.0,"shares_owned_after_display":"178,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-06","scope":"insider","n_lines":2},{"id":4398735,"accession":"0002065881-25-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002065881-25-000009","line_url":"/filing/0002065881-25-000009#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7451.0,"shares_display":"7,451","price_per_share":14.0719,"price_display":"14.07","price_state":"stated","total_value":104849.7269,"total_display":"104,849.73","total_whole":"104,850","shares_owned_after":183104.0,"shares_owned_after_display":"183,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-20","scope":"insider"},{"id":4037899,"accession":"0001787306-25-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000013","line_url":"/filing/0001787306-25-000013#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2173.0,"shares_display":"2,173","price_per_share":12.7,"price_display":"12.70","price_state":"stated","total_value":27597.1,"total_display":"27,597.10","total_whole":"27,597","shares_owned_after":135555.0,"shares_owned_after_display":"135,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":3101587,"accession":"0001787306-24-000169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-24-000169","line_url":"/filing/0001787306-24-000169#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1093.0,"shares_display":"1,093","price_per_share":7.106,"price_display":"7.11","price_state":"stated","total_value":7766.858,"total_display":"7,766.86","total_whole":"7,767","shares_owned_after":137728.0,"shares_owned_after_display":"137,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-30","filed_date":"2024-12-03","scope":"insider"},{"id":3227397,"accession":"0001787306-24-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-24-000136","line_url":"/filing/0001787306-24-000136#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer (SVP Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3725.0,"shares_display":"3,725","price_per_share":10.0122,"price_display":"10.01","price_state":"stated","total_value":37295.445,"total_display":"37,295.44","total_whole":"37,295","shares_owned_after":136635.0,"shares_owned_after_display":"136,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-03","scope":"insider"},{"id":3063599,"accession":"0001787306-24-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001787306-24-000081","line_url":"/filing/0001787306-24-000081#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001994805","owner_name":"Edwards Larry Todd","owner_display_name":"Edwards Larry Todd","owner_url":"/insider/0001994805","role":"Officer (SVP Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7640.0,"shares_display":"7,640","price_per_share":8.9767,"price_display":"8.98","price_state":"stated","total_value":68581.988,"total_display":"68,581.99","total_whole":"68,582","shares_owned_after":140360.0,"shares_owned_after_display":"140,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787306","name":"Arcutis Biotherapeutics, Inc.","url":"/issuer/0001787306","role":"Officer","n_filings":9,"first_seen":"2024-05-20","last_seen":"2026-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001994805","retrieved_at":"2026-08-25T11:28:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}